Please provide your email address to receive an email when new articles are posted on . Treating metabolic acidosis with sodium bicarbonate was associated with preserved kidney function and lower ...

In a randomized, placebo-controlled trial that enrolled patients with chronic kidney disease stages 3 and 4, sodium bicarbonate did not significant affect sit-to-stand time or bone mineral density.

Long Grove Pharmaceuticals is set to introduce Sodium Bicarbonate Injection. The product is commonly used in critical care settings yet routinely found on the drug shortages list, the company said.

Sodium bicarbonate has emerged as a notable ergogenic aid in sports science, primarily due to its ability to augment extracellular buffering capacity and mitigate the accumulation of metabolic acids ...

urine sample Oral sodium bicarbonate therapy given to patients with chronic kidney disease increases urinary pH but also increases urinary citrate levels, which may mitigate the risk for calcium ...

Cardiac surgery is one of the most common causes of acute kidney injury (AKI) worldwide. However, AKI is considered to be a potentially preventable complication of the procedure. “The ideal ...

Exela Pharma Sciences is recalling an additional 14 lots of Sodium Bicarbonate Injection, USP, 8.4%, 50mEq/50 mL vial, 20-count carton. In total, the Company is recalling 63 lots of the product due to ...

In 3 trials of sodium zirconium cyclosilicate, serum bicarbonate increased regardless of CKD stage. In addition to its potassium-binding ability, sodium zirconium cyclosilicate (SZC) may also increase ...